Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue:
Net sales	$ 283,266	$ 429,797
Cost of sales	(373,234)	(396,786)
Gross profit	(89,968)	33,011
Operating Expenses:
Research and development	(11,052,903)	(18,822,488)
Selling, general and administrative	(9,865,005)	(8,074,719)
Total operating expenses	(20,917,908)	(26,897,207)
Loss From Operations	(21,007,876)	(26,864,196)
Other Income (Expense):
Interest income	322,668	36,618
Foreign exchange transaction loss	(21,156)	(179)
Interest expense including amortization of debt discount	(787,488)	(1,873)
Total other income (expense)	(485,976)	34,566
Net Loss Before Income Taxes	(21,493,852)	(26,829,630)
Tax benefit	5,060,778
Net Loss	(16,433,074)	(26,829,630)
Other Comprehensive Income (Loss):
Unrealized gain from investments	268
Foreign currency translation (loss) gain	467	(1,911)
Total other comprehensive (loss) income	735	(1,911)
Comprehensive Loss	(16,432,339)	(26,831,541)
Net Loss	(16,433,074)	(26,829,630)
Deemed dividend as a result of warrant modification	(369,500)
Deemed dividend as a result of exchange of convertible note and Series C-2, Series D and Series F preferred stock, related party	(26,733,098)
Net Loss Attributable to Common Shareholders	$ (43,535,672)	$ (26,829,630)
Net Loss Per Common Share - Basic and Diluted	$ (1.80)	$ (1.51)
Weighted Average Common Shares Outstanding - Basic and Diluted	24,152,088	17,816,624